477 related articles for article (PubMed ID: 30249289)
1. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
[TBL] [Abstract][Full Text] [Related]
2. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
[TBL] [Abstract][Full Text] [Related]
3. SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway.
Liu G; Liu S; Cao G; Luo W; Li P; Wang S; Chen Y
Exp Cell Res; 2019 Jun; 379(1):83-91. PubMed ID: 30904482
[TBL] [Abstract][Full Text] [Related]
4. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X
Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712
[TBL] [Abstract][Full Text] [Related]
6. Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis.
Zhou H; Wang SC; Ma JM; Yu LQ; Jing JS
Med Sci Monit; 2018 Aug; 24():6021-6028. PubMed ID: 30157168
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
[TBL] [Abstract][Full Text] [Related]
8. SPAG5, the upstream protein of Wnt and the target of curcumin, inhibits hepatocellular carcinoma.
Li H; Qin Y; Huang Y; Wang J; Ren B
Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37539742
[TBL] [Abstract][Full Text] [Related]
9. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling.
Li Z; Xue TQ; Yang C; Wang YL; Zhu XL; Ni CF
J Cell Biochem; 2018 Dec; 119(12):10327-10337. PubMed ID: 30129142
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway.
Li QY; Yang K; Liu FG; Sun XG; Chen L; Xiu H; Liu XS
Clin Transl Oncol; 2020 Mar; 22(3):302-310. PubMed ID: 31625123
[TBL] [Abstract][Full Text] [Related]
11. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.
Yin Y; Li F; Li S; Cai J; Shi J; Jiang Y
Cell Physiol Biochem; 2017; 42(2):469-479. PubMed ID: 28578348
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells.
Zhang D; Wang Y; Dai Y; Wang J; Suo T; Pan H; Liu H; Shen S; Liu H
Tumour Biol; 2015 Mar; 36(3):2077-85. PubMed ID: 25391428
[TBL] [Abstract][Full Text] [Related]
13. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
Chen W; Chen X; Li S; Ren B
J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
[TBL] [Abstract][Full Text] [Related]
14. Rock2 promotes RCC proliferation by decreasing SCARA5 expression through β-catenin/TCF4 signaling.
Xu Z; Hong Z; Ma M; Liu X; Chen L; Zheng C; Xi X; Shao J
Biochem Biophys Res Commun; 2016 Nov; 480(4):586-593. PubMed ID: 27793664
[TBL] [Abstract][Full Text] [Related]
15. High expression of SPAG5 sustains the malignant growth and invasion of breast cancer cells through the activation of Wnt/β-catenin signalling.
Jiang J; Wang J; He X; Ma W; Sun L; Zhou Q; Li M; Yu S
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):597-606. PubMed ID: 30854682
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
17. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.
Huang J; Zheng DL; Qin FS; Cheng N; Chen H; Wan BB; Wang YP; Xiao HS; Han ZG
J Clin Invest; 2010 Jan; 120(1):223-41. PubMed ID: 20038795
[TBL] [Abstract][Full Text] [Related]
19. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
20. Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma.
Fu SJ; Shen SL; Li SQ; Hua YP; Hu WJ; Guo B; Peng BG
BMC Cancer; 2018 Aug; 18(1):815. PubMed ID: 30103712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
